金域医学: 广州金域医学检验集团股份有限公司股东国创开元股权投资基金(有限合伙)减持股份计划公告

Group 1 - The major shareholder, Guochuang Kaiyuan Equity Investment Fund (Limited Partnership), plans to reduce its holdings in Guangzhou Kingmed Diagnostics Group Co., Ltd. by up to 4,632,582 shares, which represents a maximum of 1.00% of the company's total share capital [4][5][6] - As of the announcement date, Guochuang Kaiyuan holds 30,880,905 shares, accounting for 6.67% of the company's total share capital, all of which were acquired prior to the company's initial public offering (IPO) [4][5] - The reduction is driven by the shareholder's personal funding needs and will be executed through centralized bidding from July 30, 2025, to October 29, 2025 [5][6] Group 2 - Guochuang Kaiyuan is not a controlling shareholder or actual controller of the company, and this reduction plan is not expected to significantly impact the company's governance structure or ongoing operations [6][7] - The shareholder has committed to comply with relevant laws and regulations regarding the reduction of shares and will disclose the progress of the reduction plan as required [6][7]